Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

3.9K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
3.9K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

7.3K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.3K
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Drug Biotransformation: Overview01:16

Drug Biotransformation: Overview

3.6K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
3.6K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

6.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.7K
Drug-Receptor Interaction: Antagonist01:28

Drug-Receptor Interaction: Antagonist

4.8K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
4.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Amide-functionalized cholic acid hybrids: design, bioactivity, and computational analysis.

RSC advances·2026
Same author

Automatic prediction of cotton leaf's diseases using deep learning techniques.

Scientific reports·2026
Same author

A framework based on hybrid Suzuki-Abe and convex Hull approach for improved classification of skin lesions.

Scientific reports·2026
Same author

Ferredoxin Feedback: A Redox Switch for Efficient Nitrogen Use in Maize.

Physiologia plantarum·2026
Same author

Sepsis and acute kidney injury-related mortality in the U.S.: National trends and disparities (1999-2023).

Medicine·2026
Same author

Missed Opportunities for Childhood Immunization in Pakistan: Failure to Vaccinate Despite Health System Contact.

Gates open research·2026

Related Experiment Video

Updated: Jan 13, 2026

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.7K

Enhanced drug-drug interaction extraction from biomedical text using deep learning-based sentence representations.

Muhammad Talha Tahir1, Muhammad Ibrahim1, Nadeem Sarwar2

  • 1Department of Computer Science, The Islamia University of Bahawalpur, Bahawalpur, Pakistan.

Scientific Reports
|October 30, 2025
PubMed
Summary
This summary is machine-generated.

A new CNN-DDI model efficiently extracts drug-drug interactions (DDIs) from biomedical text. This model achieves high accuracy, outperforming traditional and transformer-based methods while requiring fewer computational resources.

Keywords:
Adverse drug reaction (ADR)BioBERT and CNN architecturesBiomedical natural language processing (NLP)Comparative analysisDeep learning modelsDrug-drug interaction (DDI)Transformer-based models

More Related Videos

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

2.1K
Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

1.3K

Related Experiment Videos

Last Updated: Jan 13, 2026

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.7K
A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

2.1K
Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

1.3K

Area of Science:

  • Biomedical Informatics
  • Natural Language Processing
  • Machine Learning

Background:

  • Drug-drug interactions (DDIs) pose significant risks to patient safety and increase healthcare costs.
  • Traditional machine learning (ML) methods struggle with the complexity of DDI extraction from biomedical text.
  • Advanced deep learning and transformer models offer better insights but are computationally demanding.

Purpose of the Study:

  • To develop an efficient Convolutional Neural Network (CNN) model, named CNN-DDI, for extracting DDIs from biomedical literature.
  • To compare the performance of CNN-DDI against traditional ML models and state-of-the-art transformer-based models.

Main Methods:

  • Comparative analysis using the SemEval-2013 dataset.
  • Evaluation of CNN-DDI against various ML models (Logistic Regression, SVM, Random Forest, Naive Bayes, Decision Trees) and transformer models (BioBERT, RoBERTa, DeBERTa, ELECTRA, DistilBERT).
  • Standardized parameter tuning and preprocessing procedures for all models.

Main Results:

  • CNN-DDI achieved the highest overall accuracy (86.81%) and F1-score (83.81%).
  • CNN-DDI outperformed transformer-based models (best F1-score 81.41%) and traditional ML models (best F1-score 77.09%).
  • CNN-DDI demonstrated superior performance with significantly fewer computational requirements.

Conclusions:

  • CNN-DDI offers a highly effective and computationally efficient solution for DDI extraction in biomedical text mining.
  • The model presents a feasible option for large-scale analysis, balancing performance and resource demands.